Soloway Thomas P

CIK 00014542804 companiesPOINT RICHMOND, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001454280

Recent Transactions

50 trades

Other
Third Harmonic Bio, Inc.
Stock Option
2025-08-11−120,166→ 0 total
Award
Third Harmonic Bio, Inc.
Director Stock Option (right to buy)
2024-06-06+20,000→ 20,000 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−20,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−30,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−20,000→ 0 total
Award
Third Harmonic Bio, Inc.
Stock Option (right to buy)
2023-06-06+16,250→ 16,250 total
Award
Third Harmonic Bio, Inc.
Employee Stock Option (right to buy)
2023-03-06+13,667→ 13,667 total
Award
Third Harmonic Bio, Inc.
Employee Stock Option (right to buy)
2023-03-06+76,582→ 76,582 total
Disposition to Issuer
Third Harmonic Bio, Inc.
Employee Stock Option (right to buy)
2023-03-06−13,667→ 0 total
Disposition to Issuer
Third Harmonic Bio, Inc.
Employee Stock Option (right to buy)
2023-03-06−76,582→ 0 total
Award
Third Harmonic Bio, Inc.
Stock Option (right to buy)
2022-10-26+13,667→ 13,667 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-06-03+30,000→ 30,000 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-12-03+20,000→ 20,000 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-07-02+20,000→ 20,000 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−6,263→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−75,000→ 0 total
Disposition from Tender
Audentes Therapeutics, Inc.
Common Stock
2020-01-15$60.00/sh−183,384→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−3,829→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−73,781→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−65,000→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2020-01-08$2.76/sh+144,669→ 177,165 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2020-01-08$15.26/sh+6,219→ 183,384 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2020-01-08−6,219→ 73,781 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2020-01-08−144,669→ 3,829 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-12-12$59.37/sh−8,681→ 12,633 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2019-12-12$2.76/sh+41,321→ 53,954 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-12-12$59.37/sh−21,458→ 32,496 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-12-12−41,321→ 148,498 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-12-05$59.21/sh−505→ 21,314 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-09-05$31.02/sh−505→ 21,819 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-06-05$37.31/sh−1,009→ 22,324 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-02-06+65,000→ 65,000 total
Award
Audentes Therapeutics, Inc.
Common Stock
2019-02-06+23,333→ 23,333 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2017-11-16+75,000→ 75,000 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2017-01-25+80,000→ 80,000 total
Award
Paratek Pharmaceuticals, Inc.
Common Stock Option (right to buy)
2013-07-15+115,000→ 115,000 total
Award
Paratek Pharmaceuticals, Inc.
Common Stock Option (right to buy)
2013-01-07+140,000→ 140,000 total
Award
Paratek Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2012-02-01+60,000→ 60,000 total
Exercise/Conversion
Paratek Pharmaceuticals, Inc.
Employee stock option (right to buy)
2011-12-01−37,520→ 29,157 total
Exercise/Conversion
Paratek Pharmaceuticals, Inc.
Common Stock
2011-12-01$2.68/sh+25,150→ 25,150 total
Sale
Paratek Pharmaceuticals, Inc.
Common Stock
2011-12-01$8.57/sh−37,520→ 0 total
Exercise/Conversion
Paratek Pharmaceuticals, Inc.
Employee stock option (right to buy)
2011-12-01−25,150→ 38,750 total
Exercise/Conversion
Paratek Pharmaceuticals, Inc.
Common Stock
2011-12-01$0.88/sh+37,520→ 37,520 total
Sale
Paratek Pharmaceuticals, Inc.
Common Stock
2011-12-01$8.23/sh−25,150→ 0 total
Exercise/Conversion
Paratek Pharmaceuticals, Inc.
Employee stock option (right to buy)
2011-11-23−13,600→ 63,900 total
Exercise/Conversion
Paratek Pharmaceuticals, Inc.
Common Stock
2011-11-23$2.68/sh+13,600→ 13,600 total
Sale
Paratek Pharmaceuticals, Inc.
Common Stock
2011-11-23$7.87/sh−13,600→ 0 total
Award
Paratek Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2011-08-24+77,500→ 77,500 total
Award
Paratek Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2011-02-02+58,000→ 58,000 total
Award
Paratek Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2010-01-14+47,300→ 47,300 total

Companies

Recent Filings

Address

C/O TRANSCEPT PHARMACEUTICALS, INC. 1003 W. CUTTING BLVD., SUITE #110

POINT RICHMOND, CA, 94804

View on SEC.gov